Reply to: "Ductular reaction is a prognostic factor in primary biliary cholangitis".
作者信息
Carpino Guido, Cardinale Vincenzo, Carbone Marco
机构信息
Department of Anatomical, Histological, Forensic Medicine and Orthopedic Sciences, Sapienza University of Rome, Rome, 00161, Italy.
Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, 04100, Italy.
出版信息
JHEP Rep. 2023 May 3;5(8):100786. doi: 10.1016/j.jhepr.2023.100786. eCollection 2023 Aug.
Abstract
摘要
相似文献
1
Reply to: "Ductular reaction is a prognostic factor in primary biliary cholangitis".回复：“小胆管反应是原发性胆汁性胆管炎的一个预后因素”。
JHEP Rep. 2023 May 3;5(8):100786. doi: 10.1016/j.jhepr.2023.100786. eCollection 2023 Aug.
2
Role of ductular reaction and ductular-canalicular junctions in identifying severe primary biliary cholangitis.小胆管反应及小胆管-胆小管连接在识别严重原发性胆汁性胆管炎中的作用
JHEP Rep. 2022 Aug 19;4(11):100556. doi: 10.1016/j.jhepr.2022.100556. eCollection 2022 Nov.
3
Nuclear Translocation of RELB Is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.RELB 的核易位在病变人类肝脏中增加，并促进小鼠胆管反应和胆管纤维化。
Gastroenterology. 2019 Mar;156(4):1190-1205.e14. doi: 10.1053/j.gastro.2018.11.018. Epub 2018 Nov 13.
4
Loss of keratin 19 favours the development of cholestatic liver disease through decreased ductular reaction.角蛋白19的缺失通过减少小胆管反应促进胆汁淤积性肝病的发展。
J Pathol. 2015 Nov;237(3):343-54. doi: 10.1002/path.4580. Epub 2015 Aug 3.
5
Ductular reaction is a prognostic factor in primary biliary cholangitis.小胆管反应是原发性胆汁性胆管炎的一个预后因素。
JHEP Rep. 2023 Apr 6;5(8):100750. doi: 10.1016/j.jhepr.2023.100750. eCollection 2023 Aug.
6
Effects of Melittin Treatment in Cholangitis and Biliary Fibrosis in a Model of Xenobiotic-Induced Cholestasis in Mice.蜂毒素治疗对小鼠异生素诱导胆汁淤积模型中胆管炎和胆汁纤维化的影响。
Toxins (Basel). 2015 Aug 25;7(9):3372-87. doi: 10.3390/toxins7093372.
7
Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasis.bcl-2在小胆管增生中的表达与自身免疫性胆汁淤积患者的汇管区肝星状细胞活化及纤维化进展相关。
Dig Liver Dis. 2007 Mar;39(3):262-6. doi: 10.1016/j.dld.2006.12.004. Epub 2007 Jan 30.
8
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score.原发性胆汁性胆管炎患者对熊去氧胆酸应答的预处理预测：UDCA 应答评分的建立和验证。
Lancet Gastroenterol Hepatol. 2018 Sep;3(9):626-634. doi: 10.1016/S2468-1253(18)30163-8. Epub 2018 Jul 13.
9
The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice.骨桥蛋白和肿瘤坏死因子-α受体 1 在异源物诱导的胆管炎和胆管纤维化中的作用。
Lab Invest. 2010 Jun;90(6):844-52. doi: 10.1038/labinvest.2010.61. Epub 2010 Apr 5.
10
Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes.促胰液素通过恢复分泌过程减轻晚期原发性胆汁性胆管炎期间的胆道和肝脏损伤。
J Hepatol. 2023 Jan;78(1):99-113. doi: 10.1016/j.jhep.2022.07.034. Epub 2022 Aug 18.
本文引用的文献
1
Ductular reaction is a prognostic factor in primary biliary cholangitis.小胆管反应是原发性胆汁性胆管炎的一个预后因素。
JHEP Rep. 2023 Apr 6;5(8):100750. doi: 10.1016/j.jhepr.2023.100750. eCollection 2023 Aug.
2
Role of ductular reaction and ductular-canalicular junctions in identifying severe primary biliary cholangitis.小胆管反应及小胆管-胆小管连接在识别严重原发性胆汁性胆管炎中的作用
JHEP Rep. 2022 Aug 19;4(11):100556. doi: 10.1016/j.jhepr.2022.100556. eCollection 2022 Nov.
3
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.临床试验环境中接受奥贝胆酸治疗原发性胆汁性胆管炎的患者移植-free 生存率更高，与真实世界外部对照相比。
Gastroenterology. 2022 Dec;163(6):1630-1642.e3. doi: 10.1053/j.gastro.2022.08.054. Epub 2022 Sep 20.
4
Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes.促胰液素通过恢复分泌过程减轻晚期原发性胆汁性胆管炎期间的胆道和肝脏损伤。
J Hepatol. 2023 Jan;78(1):99-113. doi: 10.1016/j.jhep.2022.07.034. Epub 2022 Aug 18.
5
Cellular origins of regenerating liver and hepatocellular carcinoma.再生肝脏和肝细胞癌的细胞起源
JHEP Rep. 2021 Dec 13;4(4):100416. doi: 10.1016/j.jhepr.2021.100416. eCollection 2022 Apr.
6
Epithelial Plasticity during Liver Injury and Regeneration.肝损伤与再生过程中的上皮细胞可塑性。
Cell Stem Cell. 2020 Oct 1;27(4):557-573. doi: 10.1016/j.stem.2020.08.016. Epub 2020 Sep 23.
7
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis.熊去氧胆酸治疗原发性胆汁性胆管炎患者肝移植无生存。
J Hepatol. 2019 Aug;71(2):357-365. doi: 10.1016/j.jhep.2019.04.001. Epub 2019 Apr 11.
8
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score.原发性胆汁性胆管炎患者对熊去氧胆酸应答的预处理预测：UDCA 应答评分的建立和验证。
Lancet Gastroenterol Hepatol. 2018 Sep;3(9):626-634. doi: 10.1016/S2468-1253(18)30163-8. Epub 2018 Jul 13.
9
Hepatic Stem/Progenitor Cell Activation Differs between Primary Sclerosing and Primary Biliary Cholangitis.原发性硬化性胆管炎和原发性胆汁性胆管炎肝干细胞/祖细胞激活存在差异。
Am J Pathol. 2018 Mar;188(3):627-639. doi: 10.1016/j.ajpath.2017.11.010. Epub 2017 Dec 15.
10
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis.EASL 临床实践指南：原发性胆汁性胆管炎患者的诊断和管理。
J Hepatol. 2017 Jul;67(1):145-172. doi: 10.1016/j.jhep.2017.03.022. Epub 2017 Apr 18.
Zotero 插件